From a clinical perspective, the protective effect of exogenous MIF during ischemic heart diseases may not only be due to energy modulation, protection of cardiomyocytes and regulation of cardioprotective proteins, but also due to their rejuvenative effect on circulating stem cells. The gene discussed is MIF; the disease is coronary artery disorder.